Skip to main content

Clinical Trials › NCT06444113

Active, Not RecruitingPhase 4

Concentration of Ofatumumab in the Breast Milk of Lactating Women With Relapsing Forms of Multiple Sclerosis

Sponsored by Novartis Pharmaceuticals

Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov
24
Target enrollment
4
U.S. states
Nov 2024
Start date
Oct 2026
Expected completion

Interventions / Treatments

Ofatunumab

Conditions studied

Multiple Sclerosis

Where this trial is running (4 sites)

San Francisco
Colorado1 site
Aurora
Illinois1 site
Winfield
Brookline

MS centers in California

Compare treatment centers near a trial site by center type, providers and trials.

View California centers

More Phase 4 trials

Browse all Phase 4 MS trials
The app

Check out the MS Buddy app

Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.

Download on the App StoreGet it on Google Play